These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36881873)

  • 21. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.
    Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H
    Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.
    DeBerge M; Yeap XY; Dehn S; Zhang S; Grigoryeva L; Misener S; Procissi D; Zhou X; Lee DC; Muller WA; Luo X; Rothlin C; Tabas I; Thorp EB
    Circ Res; 2017 Sep; 121(8):930-940. PubMed ID: 28851810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internalization of apoptotic cells during efferocytosis requires Mertk-mediated calcium influx.
    Yang S; Min C; Moon H; Moon B; Lee J; Jeon J; Kwon H; Jang D; Park D
    Cell Death Dis; 2023 Jun; 14(6):391. PubMed ID: 37391432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-Resident Alveolar Macrophages Reduce Ozone-induced Inflammation via MerTK-mediated Efferocytosis.
    Guttenberg MA; Vose AT; Birukova A; Lewars K; Cumming RI; Albright MC; Mark JI; Salazar CJ; Swaminathan S; Yu Z; Sokolenko YV; Bunyan E; Yaeger MJ; Fessler MB; Que LG; Gowdy KM; Misharin AV; Tighe RM
    Am J Respir Cell Mol Biol; 2024 Jun; 70(6):493-506. PubMed ID: 38386777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of Enhanced MerTK-Dependent Macrophage Efferocytosis by Extracellular Vesicles.
    de Couto G; Jaghatspanyan E; DeBerge M; Liu W; Luther K; Wang Y; Tang J; Thorp EB; Marbán E
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2082-2096. PubMed ID: 31434491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages.
    Schilperoort M; Ngai D; Katerelos M; Power DA; Tabas I
    Nat Metab; 2023 Mar; 5(3):431-444. PubMed ID: 36797420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
    Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
    J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage.
    Rymut N; Heinz J; Sadhu S; Hosseini Z; Riley CO; Marinello M; Maloney J; MacNamara KC; Spite M; Fredman G
    FASEB J; 2020 Jan; 34(1):597-609. PubMed ID: 31914705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-Corpse Clearance after Lung Damage: The Essential Role of MerTK-mediated Alveolar Macrophage Efferocytosis.
    Haczku A
    Am J Respir Cell Mol Biol; 2024 Jun; 70(6):433-434. PubMed ID: 38502903
    [No Abstract]   [Full Text] [Related]  

  • 30. PM
    Liang S; Sun Q; Du Z; Ren X; Xu Q; Sun Z; Duan J
    Nanotoxicology; 2022 Apr; 16(3):290-309. PubMed ID: 35653618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/Mertk signaling following brain injury.
    Soliman E; Leonard J; Basso EK; Gershenson I; Ju J; Mills J; Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
    Res Sq; 2023 Jun; ():. PubMed ID: 37461720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mertk Interacts with Tim-4 to Enhance Tim-4-Mediated Efferocytosis.
    Moon B; Lee J; Lee SA; Min C; Moon H; Kim D; Yang S; Moon H; Jeon J; Joo YE; Park D
    Cells; 2020 Jul; 9(7):. PubMed ID: 32640697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically Engineered Macrophages Co-Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury.
    Tan H; Li W; Pang Z; Weng X; Gao J; Chen J; Wang Q; Li Q; Yang H; Dong Z; Wang Z; Zhu G; Tan Y; Fu Y; Han C; Cai S; Qian J; Huang Z; Song Y; Ge J
    Adv Healthc Mater; 2024 Jun; 13(16):e2303267. PubMed ID: 38198534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging.
    Santulli-Marotto S; Gervais A; Fisher J; Strake B; Ogden CA; Riveley C; Giles-Komar J
    PLoS One; 2015; 10(12):e0145078. PubMed ID: 26674639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients.
    Mohd Idrus FN; Ahmad NS; Hoe CH; Azlan M; Norfuad FA; Yusof Z; Wan Isa WYH; Mohamed Ali AA; Yvonne-Tee GB
    BMC Immunol; 2021 Mar; 22(1):21. PubMed ID: 33761885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody Cross-Linking of CD14 Activates MerTK and Promotes Human Macrophage Clearance of Apoptotic Neutrophils: the Dual Role of CD14 at the Crossroads Between M1 and M2c Polarization.
    Zizzo G; Cohen PL
    Inflammation; 2018 Dec; 41(6):2206-2221. PubMed ID: 30091033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis.
    Kayashima Y; Makhanova N; Maeda N
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
    Tajbakhsh A; Rezaee M; Kovanen PT; Sahebkar A
    Pharmacol Ther; 2018 Aug; 188():12-25. PubMed ID: 29444453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.
    Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T
    Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. We are what we eat: macrophages and efferocytosis.
    Cunningham KT; Maizels RM
    Trends Parasitol; 2024 Jun; 40(6):446-448. PubMed ID: 38772757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.